TG Therapeutics
TGTX
TGTX
222 hedge funds and large institutions have $3.21B invested in TG Therapeutics in 2021 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 79 increasing their positions, 77 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
15% less call options, than puts
Call options by funds: $71.6M | Put options by funds: $83.9M
30% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 46
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
222
Holding in Top 10
2
Calls
$71.6M
Puts
$83.9M
Top Buyers
| 1 | +$24.6M | |
| 2 | +$23.4M | |
| 3 | +$21.2M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$20.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.3M |
Top Sellers
| 1 | -$82.7M | |
| 2 | -$46.8M | |
| 3 | -$19.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.2M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$11.8M |